Filters
Canada Journal of Clinical Oncology
Year range
Funder (7)
Community (10)
Content Provider (100)
ClearCountry (71)
Filters
Canada Journal of Clinical Oncology
Year range
Funder (7)
Community (10)
Content Provider (100)
ClearCountry (71)
Loading
- publication . Article . Other literature type . 2020Open AccessAuthors:Samah Hayek; Todd M. Gibson; Wendy M. Leisenring; Jennifer L Guida; Maria M. Gramatges; Philip J. Lupo; Rebecca M. Howell; Kevin C. Oeffinger; Smita Bhatia; Kim Edelstein; ...Persistent IdentifiersPublisher: American Society of Clinical Oncology (ASCO)
PURPOSETo estimate the prevalence of frailty among childhood cancer survivors and to determine the direct and indirect effects of treatment exposures, lifestyle factors, and severe, disabling, and life-threatening chronic condition on frailty.METHODSChildhood cancer sur...
- publication . Article . 2015Authors:Traina, Tiffany A.; Miller, Kathy; Yardley, Denise A.; O'Shaughnessy, Joyce; Cortes, Javier; Awada, Ahmad; Kelly, Catherine Margaret; Trudeau, Maureen E.; Schmid, Peter; Gianni, Luca; ...Persistent IdentifiersPublisher: American Society of Clinical Oncology (ASCO)
1003 Background: The AR may be a therapeutic target for pts with androgen-driven TNBC. ENZA, a potent AR inhibitor, is approved in men with metastatic castration-resistant prostate cancer (mCRPC) and improves median PFS compared to bicalutamide in men with mCRPC (15.7 v...
- publication . Article . 2019Authors:Jennifer A. Marks; Jeffrey M. Switchenko; Conor E. Steuer; Sara Herrin; Martha A. Ryan; Mihir Patel; Mark W. El-Deiry; Jonathan J. Beitler; Dong M. Shin; Theresa W. Gillespie; ...Persistent IdentifiersPublisher: American Society of Clinical Oncology (ASCO)
e18214 Background: HPV association remains one of the most important predictors of clinical outcome in SCCHN. We aimed to determine whether the relationship between HPV status and overall survival (OS) varied by certain socioeconomic factors. Methods: Data were obtain...
- publication . Article . 2018Authors:Sally C Lau; Richard M. Lee-Ying; Davis Sam; Winson Y. Cheung;Persistent IdentifiersPublisher: American Society of Clinical Oncology (ASCO)
577 Background: With advances in diagnosis and treatment, many cancer patients survive more than 5 years. The care of these cancer survivors (CS) represent an area of unmet need. We aim to characterize the patterns of preventive care in colon CS compared to non-cancer...
- publication . Article . Other literature type . 2019Open Access EnglishAuthors:James N. Gerson; Elizabeth Handorf; Diego Villa; Alina S. Gerrie; Parv Chapani; Shaoying Li; L. Jeffrey Medeiros; Michael I. Wang; Jonathon B. Cohen; Oscar Calzada; ...Persistent IdentifiersPublisher: American Society of Clinical Oncology
PURPOSE Mantle cell lymphoma (MCL) is a B-cell lymphoma characterized by cyclin D1 expression. Autologous hematopoietic cell transplantation (AHCT) consolidation after induction chemotherapy is often used for eligible patients; however, the benefit remains uncertain in ...
- publication . Article . 2019Authors:Adam Michael Fundytus; Yunting Fu; Lorraine Shack; Truong-Minh Pham; Winson Y. Cheung;Persistent IdentifiersPublisher: American Society of Clinical Oncology (ASCO)
e18238 Background: EGFR/ALK inhibitors and immunotherapy represent promising treatments for metastatic NSCLC, but patients must be referred to a cancer center (CC) to be considered for these treatments. Local referral rates to a CC for advanced pancreatic cancer are o...
- publication . Article . 2020Authors:Irene S. Yu; Shiru Lucy Liu; Yizhou Zhao; S. Lau; Howard John Lim;Persistent IdentifiersPublisher: American Society of Clinical Oncology (ASCO)
452 Background: The utility of PET scans (PETs) to predict outcomes after neoadjuvant treatment of DE/GEJ cancers is unclear. We aimed to explore the relationship between PET response and pathologic/clinical outcomes in a real-world setting. Methods: Patients (pts) wi...
- publication . Article . Conference object . 2015Authors:John A. Thompson; Robert J. Motzer; Ana M. Molina; Toni K. Choueiri; Elisabeth I. Heath; Christian K. Kollmannsberger; Bruce G. Redman; Randeep Sangha; D. Scott Ernst; Roberto Pili; ...Persistent Identifiers
2503 Background: ENPP3 is expressed in greater than 90% of clear cell (CC) and 70% of papillary (PAP) RCC and represents an interesting target in this disease. Hybridoma-derived AGS-16M8F and CHO-d...
- publication . Article . 2001Authors:Daniel Rayson; Shirley Ruedy;Persistent IdentifiersPublisher: American Society of Clinical Oncology (ASCO)
- publication . Article . 2012Authors:Caroline Dorothy Lynch; Elkanah Omenge; Peter Itsura; Hellen Muliro; Guiseppe DelPriore; Barry P. Rosen; Sierra Washington; Robert Matthew Strother;Persistent IdentifiersPublisher: American Society of Clinical Oncology (ASCO)
5107 Background: To compare HIV+ and HIV- women with operable cervical cancer in a low resource contemporary setting. Methods: A retrospective study using well-matched controls from a Kenyan teaching and referral hospital. Results: 183 women were treated for cervical ...